Retrospective study to investigate background factors affecting occurrence of nephrotoxicity and recovery from the nephrotoxicity on L-AMB using Electric Medical Data

Retrospective study to investigate background factors affecting occurrence of nephrotoxicity and recovery from the nephrotoxicity on L-AMB using Electric Medical Data - Retrospective study to investigate background factors affecting occurrence of nephrotoxicity and recovery from the nephrotoxicity on L-AMB using Electric Medical Data

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032613

Enrollment

600

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotoxicity

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 18 years old at the initial L-AMB administration Have received L-AMB administration at least once Serum creatinine is measured at least twice as follows once on the start date of L-AMB administration or within 7days before the initial L-AMB administration once on the last date of L-AMB administration or within 7 days after last of L-AMB administration

Exclusion criteria

Exclusion criteria: Total L-AMB dose administration of per day for per 1kg of body weight has ever exceeded 6mg (titer) during L-AM administration period

Design outcomes

Primary

Measure	Time frame
To investigate background factors affecting occurrence of nephrotoxicity and recovery from the nephrotoxicity on L-AMB.	—

Countries

Japan

Contacts

Public ContactMASATO TASHIRO

Nagasaki University Graduate School of Biomedical Sciences Department of INFECTIOUS DISEASES

mtashiro@nagasaki-u.ac.jp095-819-7184

Outcome results